Platelet Rich Plasma Treatment for Chronic Achilles Tendinosis

Foot and Ankle International - Tập 33 Số 5 - Trang 379-385 - 2012
Raymond Rocco Monto1
1Nantucket Cottage Hospital, Orthopedic Surgery, Nantucket, MA 02554, USA. [email protected]

Tóm tắt

Background: Chronic Achilles tendinosis is a relatively common but difficult orthopedic condition to treat. In this study, autologous platelet rich plasma (PRP), a concentrated bioactive blood component rich in cytokines and growth factors, was evaluated to determine its potential long-term efficacy in treating chronic cases of Achilles tendinosis resistant to traditional nonoperative management. Methods: Thirty patients with chronic Achilles tendinosis who did not respond to a minimum of 6 months of traditional nonoperative treatment modalities were treated with a single ultrasound guided injection of PRP. AOFAS scoring was completed for all patients pretreatment and at 0, 1, 2, 3, 6, 12, and 24 months post-treatment. MRI and/or ultrasound studies were completed for all patients pre-treatment and at 6 months post-treatment. Prior to the PRP treatment all of the patients in this study were considering surgical Achilles repair for their severe symptoms. Results: The average AOFAS score increased from 34 (range, 20 to 60) to 92 (range, 87 to 100) by 3 months after PRP treatment and remained elevated at 88 (range, 76 to 100) at 24 months post-treatment. Pretreatment imaging abnormalities present in the Achilles tendon on MRI and ultrasound studies resolved in 27 of 29 patients at 6 months post-treatment. Clinical success was achieved in 28 of 30 patients. Conclusion: Platelet-rich plasma was used effectively to treat chronic recalcitrant cases of Achilles tendinosis. Level of Evidence: IV, Case Series

Từ khóa


Tài liệu tham khảo

10.1136/bjsm.2007.035543

10.1002/jcp.22274

10.1016/j.orthres.2004.08.015

10.1097/01.prs.0000255543.43695.1d

10.1080/00016470410001708190

10.1097/00003086-199507000-00021

Barrett S, 2004, Podiatry Today., 17, 37

10.1177/036354658401200301

10.1136/bjsm.2007.040071

10.1177/107110070302400306

10.1136/bjsm.2010.081554.40

10.1177/0363546508314430

10.1001/jama.2009.1986

10.1136/bjsm.2010.079822

10.1097/01.PRS.0000138251.07040.51

10.1159/000110862

10.2106/JBJS.I.01158

10.1097/01.bto.0000261868.03232.dd

10.1016/j.injury.2008.06.025

10.5435/00124635-200910000-00002

10.1177/0363546508330974

10.1002/jcp.21368

10.1136/bjsm.37.2.149

10.1016/j.injury.2008.11.026

10.3113/FAI.2009.1101

Maffulli N, 2010, J. Bone Joint Surg Am., 92, 2604

10.1136/bjsm.21.4.158

10.1016/j.joms.2003.12.003

10.1302/0301-620X.82B1.8954

10.1002/jor.20853

10.1177/107110070202300104

10.1177/0363546506288850

10.1016/j.csm.2008.08.007

10.1016/j.arthro.2009.12.017

10.3113/FAI.2007.0472

10.1016/j.arthro.2008.07.016

10.2106/00004623-200211000-00024

10.3109/02841859809175485

10.3113/FAI.2007.1064

10.1080/09638280801906081

10.5435/00124635-200901000-00002

10.2106/JBJS.F.01494

10.5435/00124635-199809000-00007

Sanchez M, 2008, Clin Exp Rheumatol., 26, 910

Sanchez M, 2007, Am J Sports Med., 37, 837, 10.2165/00007256-200737100-00002

10.1249/01.MSS.0000089344.44434.50

10.1177/036354658701500403

10.1177/036354659402200508

10.1002/jor.20278

10.2165/00007256-200737100-00002

10.1002/jcp.21212

10.1007/s00167-009-0762-8

10.1080/17453670610013033

10.1177/107110070002101204

Zavadil D, 2007, JECT., 39, 177, 10.1051/ject/200739177